ASCO: Definiens debuts digital pathology image analysis software

Manjula Puthenedam, PhD, | | Health Imaging | Molecular Imaging
Definiens presented its image analysis software for use in clinical trials and translational research at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago this week.

The company, headquartered in Munich, said its digital pathology image analysis software, Tissue Studio allows pathologists to identify, quantify and interpret biomarkers and cellular morphology in tissue samples on a cell-by-cell basis.

Manjula Puthenedam, PhD,

Related Content

Novel radiotracer could improve the diagnosis of interstitial lung disease
New tau imaging agent granted FDA's Fast Track designation
New PET technique slashes scan times, improves image quality in neuroblastoma cases
FAPI PET improves staging and clinical management for a significant portion of pancreatic cancers
Hall of Fame Health partnership set to advance study of neurodegeneration via new PET imaging agent
Pharmacist pleads guilty to 'adulterating' radiopharmaceuticals

Around the web

Cardiovascular Business
Cath lab techs and nurses see new normal with post-COVID pay

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Radiology Business
The pros and cons of current breast screening modalities and the role of AI

Debra L. Monticciolo, MD, past president of both the Society of Breast Imaging and the American College of Radiology, explains the advantages and disadvantages of current breast screening technology.

Cardiovascular Business
ASE shares new guideline on imaging patients with implanted devices

The new guideline details the best imaging strategies for a variety of clinical scenarios. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup